leishmaniasi
longstand
infecti
diseas
repres
major
public
health
problem
variou
tropic
subtrop
region
world
trouiller
et
al
estim
around
one
billion
individu
suffer
one
parasit
infect
greatest
caus
morbid
attribut
trypanosomatid
parasit
varieti
leishmania
organ
approxim
speci
report
caus
diseas
afflict
million
peopl
countri
indian
subcontin
sudan
brazil
major
region
incid
leishmaniasi
balanafouc
et
al
dorlo
et
al
estim
annual
number
new
case
leishmaniasi
million
usual
fatal
current
vaccin
avail
diseas
necessit
develop
altern
strategi
limit
transmiss
infect
modabb
current
treatment
regimen
diseas
includ
amphotericin
b
miltefosin
paromomycin
howev
ideal
often
associ
sever
side
effect
murray
emerg
resist
current
use
drug
exacerb
need
identifi
novel
drug
target
develop
new
drug
berman
drug
like
amphotericin
b
caus
hepatotox
nephrotox
wherea
miltefosin
caus
sever
teratogen
pandey
et
al
plant
extract
plantderiv
compound
proven
valuabl
sourc
new
medicin
agent
de
carvalho
ferreira
kayser
kiderlen
advoc
use
tradit
medicin
appropri
health
servic
inaccess
ei
tahir
et
al
wenig
et
al
bhadra
furthermor
lead
obtain
search
natur
product
antileishmani
activ
give
new
impetu
obtain
valuabl
synthet
compound
carvalho
et
al
recent
attent
focus
sterol
metabol
leishmania
potenti
molecular
drug
target
therapi
parasit
synthes
sterol
isoprenoid
via
mevalon
pathway
ergosterol
primari
compon
leishmania
membran
function
link
mainten
structur
integr
protect
biotic
stress
galea
brown
coenzym
reductas
hmgr
key
enzym
pathway
mevalon
pathway
directli
relev
human
health
inhibit
hmgr
statin
control
sterol
product
lower
blood
pressur
help
treatment
cardiovascular
diseas
inflammatori
process
liao
lauf
l
donovani
pathway
current
explor
potenti
drug
target
glycyrrhiza
glabra
popularli
known
liquoric
one
import
medicin
plant
use
treatment
pulmonari
diseas
inflammatori
process
davi
morri
major
bioactiv
compon
liquoric
root
includ
glycyrrhiz
acid
ga
licochalon
glycyrrhetin
acid
report
exert
antileishmani
properti
bhattacharje
et
al
fu
et
al
ukil
et
al
ga
report
exhibit
potent
antileishmani
immunomodulatori
properti
enhanc
parasit
clearanc
bhattacharje
et
al
besid
ga
shown
broad
spectrum
antimicrobi
antiprotozo
antiallerg
antivir
anticanc
antioxid
antiinflammatori
activ
variou
pharmacolog
effect
multipl
site
action
kumagai
et
al
lin
hibasami
et
al
fujisawa
et
al
ga
report
suppress
rise
fast
blood
glucos
insulin
level
improv
glucos
toler
takii
et
al
ga
inhibit
replic
sever
acut
respiratori
syndrom
viru
sar
hoever
et
al
ga
involv
treatment
hepat
c
viru
hcv
infect
inhibit
hcv
viral
particl
gene
express
dosedepend
manner
shown
synergist
effect
interferon
ga
affect
variou
cellular
signal
pathway
casein
kinas
ii
protein
kinas
c
transcript
factor
power
antiinflammatori
capabl
ga
make
effect
treatment
variou
type
viral
hepat
also
ashfaq
et
al
sever
mechan
propos
mode
action
ga
l
donovani
bhattacharje
et
al
report
prostaglandin
inhibit
gener
mechan
action
ga
thu
suggest
potenti
immunomodulatori
role
ga
vl
bhattacharje
et
al
recent
ga
report
reduc
parasit
load
sodium
antimoni
glucon
sag
resist
l
donovani
infect
macrophag
ga
use
combin
sag
intracellular
antimoni
level
greatli
reduc
suppress
cell
surfac
express
multidrug
resistanceassoci
gene
abc
transport
mrpa
pgpa
transport
respons
antimoni
efflux
sag
treatment
bhattacharje
et
al
earlier
report
suggest
ga
effect
lipidlow
agent
hamster
diet
induc
hyperlipidemia
effect
demonstr
via
decreas
hmgr
activ
hmgr
mrna
express
maurya
srivastava
led
us
investig
effect
l
donovani
parasit
hmgr
activ
ergosterol
level
view
potenti
use
ga
specif
treatment
parasit
diseas
like
leishmaniasi
tri
elucid
effect
sterol
metabol
parasit
studi
reveal
interfer
parasit
sterol
metabol
inhibit
hmgr
activ
lower
ergosterol
level
glycyrrhiz
acid
ergosterol
methanol
solvent
purchas
sigmaaldrich
st
loui
mo
usa
atorvastatin
kind
gift
dr
suresh
niper
sa
nagar
india
polyclon
antirat
hmgr
antibodi
kindli
gift
dr
peter
edward
ucla
laboratori
lo
angel
ca
et
al
antildacec
antibodi
custom
imgenex
bhubaneshwar
india
soumya
et
al
wild
type
l
donovani
wt
promastigot
maintain
c
hepe
modifi
medium
gibcobrl
life
technolog
scotland
uk
contain
heatinactiv
foetal
bovin
serum
hifb
supplement
sodium
bicarbon
mgml
penicillin
mgml
streptomycin
mgml
gentamycin
ph
media
maintain
ldhmgr
overexpress
transgen
promastigot
maintain
medium
mgml
hygromycin
b
monocyt
cell
line
maintain
medium
contain
hifb
humidifi
atmospher
co
c
promastigot
l
donovani
strain
grown
medium
mention
earlier
two
hundr
microlit
cultur
cell
densiti
promastigot
without
variou
ga
concentr
mm
seed
microtit
plate
h
incub
c
ml
mgml
tetrazolium
bromid
mtt
dye
ad
well
plate
incub
anoth
h
c
read
biotek
micropl
reader
nm
decreas
absorb
indic
inhibit
express
percentag
absorb
control
cultur
plot
drug
concentr
inhibitori
concentr
ic
calcul
sigmoid
inhibit
curv
data
express
mean
standard
deviat
three
independ
experi
antileishmani
screen
l
donovani
amastigot
resid
differenti
monocyt
adapt
jain
cowork
jain
et
al
monocyt
seed
densiti
well
plate
differenti
macrophag
induc
phorbol
pma
ngml
macrophag
infect
l
donovani
promastigot
c
co
h
unadh
promastigot
remov
wash
medium
amastigoteinfect
macrophag
treat
ga
differ
concentr
mm
h
infect
macrophag
lyse
treat
cell
ml
sodium
dodecyl
sulfat
sd
amastigot
revert
back
promastigot
suitabl
condit
h
mtt
assay
perform
describ
earlier
miltefosin
use
standard
antileishmani
drug
estim
inhibitori
concentr
ga
viabil
thp
cell
line
mtt
assay
perform
previous
describ
mosmann
briefli
thp
cell
ml
seed
microlit
plate
c
co
h
incub
vari
concentr
mm
ga
ad
fresh
medium
mtt
ad
h
incub
follow
h
incub
c
cell
harvest
violet
crystal
dissolv
dmso
final
od
measur
nm
use
micro
plate
reader
effect
ga
growth
wild
type
promastigot
determin
cm
flask
initi
cellsml
seed
c
medium
supplement
heat
inactiv
fetal
bovin
serum
cell
densiti
determin
neubauer
hemocytomet
everi
h
interv
five
day
h
inhibitori
concentr
gla
mm
ad
cell
h
growth
ga
treat
promastigot
compar
untreat
promastigot
order
express
recombin
l
donovani
hmgr
protein
e
coli
cell
transform
construct
recombin
ldhmgr
enzym
purifi
use
affin
chromatographi
report
earlier
ldhmgr
enzym
activ
measur
carri
determin
effect
ga
activ
recombin
l
donovani
hmgr
enzym
presenc
differ
concentr
ga
min
incub
oxid
nadph
monitor
nm
one
unit
u
hmgr
defin
amount
enzym
requir
catalyz
oxid
mmol
nadph
per
min
atorvastatin
chemic
inhibitor
hmgr
taken
posit
control
variou
concentr
atorvastatin
rang
nm
use
assay
approxim
cell
grown
h
treat
ic
concentr
ga
mm
atorvastatin
mm
h
c
atorvastatin
taken
posit
control
hmgr
inhibit
cell
harvest
min
wash
pb
cell
pellet
resuspend
lysi
buffer
mm
kh
po
ph
mm
dtt
mm
pmsf
mgml
leupeptin
lyse
repeat
freez
thaw
cycl
liquid
nitrogen
c
cell
lysat
extract
centrifug
min
c
cell
lysat
untreat
parasit
taken
control
hmgr
activ
carri
describ
earlier
use
equal
amount
untreat
ga
treat
atorvastatin
treat
total
cell
lysat
protein
immunoblot
promastigot
inocul
cm
tissu
cultur
flask
treat
ic
concentr
ga
h
cell
lyse
describ
section
approxim
mg
protein
sampl
subject
sdspage
transfer
onto
nitrocellulos
membran
electroblot
biorad
v
h
membran
incub
polyclon
antirat
hmgr
antibodi
overnight
c
temperatur
follow
antirabbit
igg
alkalin
phosphatas
conjug
secondari
antibodi
h
specif
protein
band
visual
incub
nitro
blue
tetrazolium
nbt
phosphat
disodium
salt
bcip
substrat
densitometr
analysi
blot
perform
use
imag
j
softwar
acetyl
coa
synthetas
earlier
report
lab
use
neg
control
show
specif
effect
ga
hmgr
soumya
et
al
solut
mgml
ergosterol
serv
control
inject
volum
ml
agil
technolog
c
column
mm
mm
mm
particl
use
rphplc
evalu
effect
ga
ergosterol
biosynthesi
promastigot
approxim
cellsml
seed
cultur
flask
h
incub
cell
treat
ga
ic
concentr
incub
h
cell
harvest
sampl
prepar
hplc
report
earlier
ng
et
al
appropri
control
without
ga
treatment
also
taken
studi
perform
examin
rescu
ga
treat
l
donovani
promastigot
upon
ergosterol
supplement
briefli
promastigot
seed
plate
h
treat
ga
ic
concentr
cell
simultan
supplement
exogen
ergosterol
vari
concentr
mmoll
dissolv
methanol
cell
supplement
mmoll
ergosterol
control
percentag
promastigot
live
upon
rescu
analyz
mtt
assay
assay
perform
triplic
growth
control
solvent
solvent
plu
ergosterol
includ
verifi
lack
promastigot
growth
inhibitori
effect
confirm
specif
ga
toward
l
donovani
hmgr
use
previous
gener
hmgr
overexpressor
promastigot
describ
earlier
briefli
late
log
phase
wild
type
overexpress
promastigot
seed
flat
bottom
plate
incub
h
c
examin
effect
ga
parasit
incub
rang
concentr
ga
mm
h
h
incub
mtt
mgml
ml
per
well
ad
well
plate
incub
addit
h
c
cell
harvest
result
pellet
dissolv
dmso
final
absorb
measur
nm
oneway
analysi
varianc
anova
perform
comparison
group
statist
analysi
data
done
use
graph
pad
prism
softwar
version
valu
p
consid
signific
chemic
structur
ga
shown
fig
determin
dosedepend
effect
ga
l
donovani
promastigot
cell
plate
variou
concentr
investig
compound
viabil
assess
h
exposur
drug
use
mtt
assay
presenc
ga
dosedepend
inhibit
viabil
l
donovani
promastigot
observ
concentr
ga
requir
inhibit
parasit
viabil
determin
plot
drug
concentr
viabil
promastigot
assum
control
without
drug
viabl
ic
determin
graph
mm
cytotox
properti
ga
macrophag
determin
microlit
plate
mtt
assay
result
express
concentr
ga
inhibit
cell
viabil
control
macrophag
cell
treat
vari
concentr
ga
h
use
standard
drug
miltefosin
posit
control
ga
caus
macrophag
kill
upto
mm
concentr
refer
drug
miltefosin
howev
decreas
viabil
macrophag
mm
concentr
data
shown
ga
found
inhibit
intracellular
amastigot
dose
depend
manner
ic
valu
mm
comparison
ic
cytotox
concentr
cc
valu
obtain
ga
miltefosin
repres
tabl
select
index
si
calcul
divid
cc
valu
thp
cell
line
ic
valu
amastigot
si
calcul
ga
found
wherea
miltefosin
tabl
determin
inhibitori
effect
ga
growth
wild
type
promastigot
parasit
growth
l
donovani
promastigot
monitor
period
h
parasit
enumer
everi
h
count
use
hemocytomet
ic
concentr
ga
mm
ad
h
result
show
ga
affect
growth
l
donovani
promastigot
decreas
growth
rate
fold
h
fold
h
ga
treat
promastigot
compar
untreat
wild
type
promastigot
observ
fig
data
reveal
ga
affect
prolifer
l
donovani
promastigot
investig
effect
ga
catalyt
effici
recombin
hmgr
enzym
use
assay
express
purifi
report
earlier
ga
test
rang
mm
concentr
halfmaximum
inhibitori
concentr
found
mm
higher
concentr
mm
ga
residu
hmgr
activ
observ
indic
ga
bind
hmgr
caus
inhibit
fig
left
panel
atorvastatin
use
posit
control
compar
analysi
ga
ldhmgr
inhibitor
fig
right
panel
mm
approxim
inhibit
observ
ic
valu
calcul
nm
correl
previous
report
data
atorvastatin
sensit
inhibitor
hmgr
ga
inhibit
enzym
lower
micromolar
rang
hmgr
activ
also
measur
promastigot
absenc
presenc
ga
ga
treat
promastigot
reduct
hmgr
activ
comparison
untreat
parasit
promastigot
treat
mm
atorvastatin
exhibit
inhibit
thu
serv
posit
control
inhibitor
hmgr
fig
effect
ga
hmgr
protein
express
evalu
western
blot
l
donovani
cell
extract
obtain
promastigot
treat
ic
concentr
ga
blot
stain
ponceau
serv
load
control
densitometr
analysi
blot
reveal
fivefold
reduct
hmgr
express
ga
treat
promastigot
confirm
effect
ga
hmgr
fig
prove
specif
ga
hmgr
randomli
select
acetylcoa
synthetas
acec
control
protein
report
acec
target
ga
densitometr
analysi
reveal
chang
express
acec
promastigot
treat
ga
fig
standard
hplc
method
use
isol
neutral
lipid
l
donovani
promastigot
retent
time
ergosterol
extract
promastigot
found
min
correl
standard
ergosterol
peak
retent
time
fig
hplc
chromatogram
wild
type
control
parasit
ga
treat
parasit
mm
shown
fig
left
right
panel
respect
reveal
almost
reduct
ergosterol
level
ga
treat
wild
type
promastigot
peak
area
wild
type
control
ga
treat
promastigot
respect
also
estim
ergosterol
level
hmgr
overexpress
untreat
ga
treat
l
donovani
promastigot
mm
seen
fig
left
right
panel
respect
result
show
reduct
ergosterol
level
hmgr
overexpressor
upon
treatment
ga
comparison
wild
type
reduct
observ
peak
area
hmgr
overexpress
control
ga
treat
promastigot
found
respect
calcul
rel
peak
area
wild
type
control
consid
observ
ergosterol
level
hmgr
overexpressor
fold
higher
compar
wild
type
promastigot
wild
type
hmgr
overexpressor
treat
ic
concentr
ga
wild
type
parasit
fold
reduct
ergosterol
level
compar
hmgr
overexpressor
fig
ga
treat
leishmania
promastigot
cultur
exogen
supplement
differ
concentr
ergosterol
studi
role
exogen
sterol
overcom
ga
mediat
inhibit
ergosterol
rescu
ga
treat
promastigot
concentr
rang
mmoll
caus
revers
ga
mediat
growth
inhibit
fig
promastigot
treat
ic
valu
ga
show
inhibit
wherea
case
ga
treat
promastigot
supplement
mmoll
ergosterol
show
inhibit
e
revers
inhibit
result
indic
ga
inhibit
occur
interf
ergosterol
biosynthesi
key
sterol
compon
surviv
parasit
solvent
solvent
plu
ergosterol
taken
control
background
inhibit
observ
effect
glycyrrhiz
acid
l
donovani
transfect
overexpress
hmgr
l
donovani
promastigot
overexpress
hmgr
maintain
medium
constant
select
pressur
hygromycin
b
halfmaximum
inhibitori
concentr
ic
mm
mm
wild
type
ldhmgr
overexpress
cell
respect
ldhmgr
overexpressor
fold
increas
ic
ga
compar
wildtyp
promastigot
fig
result
indic
higher
concentr
drug
need
case
ldhmgr
overexpress
cell
compar
wild
type
obtain
similar
therapeut
result
result
support
hmgr
overexpress
promastigot
show
resist
ga
depict
prime
role
inhibit
sterol
biosynthet
pathway
hmgcoa
reductas
enzym
catalyz
convers
hmgcoa
mevalon
precursor
cholesterol
human
ergosterol
plant
fungi
protozoa
henriksen
et
al
macreadi
et
al
ergosterol
report
essenti
growth
replic
leishmania
fungi
kulkarni
et
al
efficaci
ergosterol
biosynthesi
inhibitor
antiprolif
agent
trypanosoma
cruzi
alreadi
report
urbina
et
al
hmgr
propos
potenti
drug
target
l
donovani
sever
natur
synthet
statin
report
interfer
growth
l
donovani
inhibit
hmgr
besid
sever
compound
natur
sourc
like
cholestin
diosgenin
ga
report
inhibit
hmgr
arguel
et
al
maurya
srivastava
past
year
well
document
plant
sourc
use
treat
inflamm
asthma
bronchiti
tumor
fungal
diseas
recent
ga
analog
also
report
antifilari
agent
pandey
et
al
kim
et
al
kalani
et
al
sever
mechan
propos
ga
mediat
inhibit
includ
antiinflammatori
properti
ga
suppress
tnfa
antiapoptot
effect
via
suppress
explain
hepatoprotect
properti
nasyrov
et
al
wan
et
al
part
drug
discoveri
research
interest
natur
product
entiti
could
target
sterol
biosynthet
pathway
serv
antileishmani
agent
came
across
ga
literatur
search
reveal
antileishmani
activ
ga
prove
efficaci
caus
enhanc
releas
cytokin
tnfa
leishmania
infect
macrophag
thu
indic
immunomodulatori
properti
bhattacharje
et
al
cytokin
play
import
role
control
diseas
progress
viscer
leishmaniasi
descoteaux
matlashewski
mcsorley
et
al
taylor
murray
find
prompt
us
investig
mechan
antileishmani
action
ga
leishmania
promastigot
work
investig
first
time
effect
ga
sterol
metabol
parasit
result
present
studi
show
vitro
growth
suppress
l
donovani
promastigot
intracellular
amastigot
ga
result
indic
ga
exert
antileishmani
action
signific
reduct
parasit
viabil
concentr
far
cytotox
concentr
earlier
report
mgml
ga
reduc
parasit
burden
l
donovani
infect
murin
periton
macrophag
mgml
result
inhibit
bhattacharje
et
al
result
show
ga
display
antileishmani
activ
noncytotox
concentr
standard
drug
miltefosin
fold
higher
sensit
promastigot
fold
higher
sensit
amastigot
compar
ga
howev
select
index
ga
almost
compar
miltefosin
sensit
promastigot
amastigot
macrophag
toward
miltefosin
agreement
previous
publish
data
corral
et
al
calogeropoul
et
al
dube
et
al
earlier
studi
show
hmgr
mrna
express
markedli
decreas
ga
treat
dyslipidem
hamster
maurya
srivastava
keep
view
effect
ga
studi
recombin
hmgr
nativ
enzym
promastigot
mm
concentr
ga
recombin
ldhmgr
activ
reduc
interestingli
found
ga
inhibit
recombin
enzym
ic
valu
close
ic
valu
obtain
cell
base
inhibit
studi
suggest
ga
might
specif
bind
ldhmgr
enzym
hmgr
activ
also
measur
ga
treat
l
donovani
promastigot
reduct
observ
observ
recombin
enzym
inhibit
ga
compar
inhibit
nativ
enzym
l
donovani
promastigot
inhibit
recombin
hmgr
mm
ga
wherea
inhibit
nativ
hmgr
l
donovani
promastigot
observ
mm
ga
concentr
differ
effect
ga
recombin
enzym
activ
parasit
enzym
activ
may
due
multitarget
effect
ga
bhattacharje
et
al
moreov
effect
ga
promastigot
measur
whole
cell
lysat
parasit
purifi
nativ
hmgr
enzym
nativ
recombin
hmgr
inhibit
studi
atorvastatin
use
chemic
inhibitor
hmgr
enzym
act
posit
control
fivefold
lower
hmgr
express
observ
immunoblot
indic
specif
ga
hmgr
thu
reduct
hmgr
enzym
activ
associ
reduct
hmgr
protein
level
acec
select
control
protein
howev
ga
multitarget
effect
proteom
provid
inform
regard
target
also
confirm
ga
treatment
reduc
biosynthesi
ergosterol
inhibit
hmgr
enzym
ergosterol
level
ga
treat
wild
type
promastigot
significantli
decreas
wherea
reduct
observ
ga
treat
hmgr
overexpressor
explain
affect
sterol
biosynthesi
parasit
one
reason
parasit
kill
moreov
attempt
made
revers
ga
mediat
growth
inhibit
ergosterol
could
partial
reviv
growth
studi
clearli
indic
though
ga
act
inhibit
ldhmgr
enzym
alter
ergosterol
level
yet
sole
target
ga
well
document
ga
multipl
mechan
action
multipl
target
parasit
recent
report
state
inhibit
enzym
lead
increas
gener
l
donovani
infect
macrophag
thu
arrest
parasit
surviv
bhattacharje
et
al
order
valid
effect
ga
hmgr
enzym
effect
ga
test
wild
type
hmgr
overexpress
transgen
parasit
report
earlier
studi
result
indic
hmgr
overexpress
parasit
fold
resist
toward
ga
mediat
inhibit
promastigot
compar
nontransgen
parasit
therefor
illustr
episom
express
hmgr
parasit
protect
ga
induc
lysi
evid
higher
concentr
ga
requir
inhibit
transgen
parasit
wild
type
parasit
interfer
ergosterol
biosynthesi
result
disrupt
parasit
function
molecul
involv
pathway
could
serv
potenti
drug
target
antileishmani
chemotherapi
de
souza
rodrigu
interestingli
report
leishmania
surviv
alter
sterol
level
howev
chang
sterol
profil
link
amphotericin
b
fluconazol
resist
mbongo
et
al
robert
et
al
alter
sterol
level
could
import
implic
drug
respons
ergosterol
requir
action
drug
exampl
amphotericin
b
polyen
antifung
drug
also
use
treatment
leishmaniasi
associ
ergosterol
action
croft
et
al
cohen
conclus
result
work
extend
investig
ga
potenti
candid
viscer
leishmaniasi
treatment
overal
mode
action
ga
vitro
studi
via
inhibit
hmgr
enzym
rate
limit
enzym
sterol
biosynthet
pathway
deplet
ergosterol
level
culmin
parasit
death
best
knowledg
first
report
conclus
prove
ga
use
potenti
inhibitor
l
donovani
hmgr
interest
molecul
possess
immunomodulatori
properti
analyz
perform
mtt
assay
chang
od
measur
nm
use
well
plate
reader
data
express
mean
standard
deviat
three
independ
experi
p
p
fig
comparison
effect
glycyrrhiz
acid
growth
profil
wild
type
hmgr
overexpressor
promastigot
incub
vari
concentr
ga
h
viabil
measur
use
mtt
assay
data
express
mean
standard
deviat
three
independ
experi
ministri
chemic
fertil
india
nplc
sushma
singh
special
thank
director
niper
financi
support
special
thank
mr
neerupudi
kishor
babu
critic
read
manuscript
